Events

Recall of Platinium Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronisation Therapy Defibrillators (CRT-Ds)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by LivaNova Australia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2017-RN-00913-1
  • Event Risk Class
    Class III
  • Event Initiated Date
    2017-08-17
  • Event Country
    Australia
  • Event Source
    DHTGA
  • Event Source URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2017-RN-00913-1
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Livanova has identified an issue of overconsumption following an electrostatic discharge (esd) during implant surgery or an mri scan.An electronic component in specific platinium devices has been found to be sensitive to esd, potentially generated during surgery. the discharge can trigger overconsumption of current, leading to reduced device longevity (5% loss per month). resetting the device will stop the overconsumption, but the residual longevity displayed by the programmer may be temporarily underestimated.Exposure to an mri's magnetic field can cause overconsumption, & the battery voltage will decrease to 2.80v. at this level, the remaining longevity is 25% of the initial longevity. to date, no permanent injury or death has occurred as a result of these issues. as of 16 june 2017, livanova has received 18 reports of overconsumption associated with esd exposure at implant, (0.19%), & 4 reports of overconsumption/premature device replacement attributed to mri (0.04%).
  • Action
    In order to mitigate the potential risks associated with both triggering events (ESD/MRI scan), LivaNova recommends physicians follow-up patients at the periodicity already stated in the implant manual, especially: - Before the patient is discharged & at each subsequent follow-up, check the battery status & the occurrence of system warnings; - It is recommended that a routine follow-up examination be done 1 month after discharge, & then every 3 months until the device nears the replacement date. LivaNova does not recommend anticipating patient visits, provided that the IFU is followed. If the warning “[A3] Technical issue” is displayed, this indicates that the device is affected by the overconsumption caused by an ESD at implant. Without delay, contact your LivaNova representative who will organise the reset of the device. Complete and return the supplied Customer Reply Form ASAP. For further information, please see https://www.tga.gov.au/alert/platinum-icds-and-crt-ds

Device

Platinium Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronisation Therapy Defibri...
  • Model / Serial
    Platinium Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronisation Therapy Defibrillators (CRT-Ds)Platinium VR 1210Platinium VR 1240Platinium DR 1510Platinium DR 1540Platinium CRT-D 1711Platinium CRT-D 1741Platinium SONR CRT-D 1811Platinium SONR CRT-D 1841ARTG Numbers: 282817, 282816, 282818, 282819, 282820, 282821, 282822 and 282823
  • Manufacturer
    LivaNova Australia Pty Ltd

Manufacturer

LivaNova Australia Pty Ltd